NASDAQ Equity Snapshot

KNSA Weekly Equity Report

Kiniksa Pharmaceuticals Ltd

Interactive chart JSON snapshot
Latest Close 51.89 USD 12 Jun 2026
1W Return 7.2% latest completed week
4W Return -8.2% short-term follow-through
12W Return 12.6% quarterly tape
Trend Breadth 100.0% 52 of 52 weeks active
Volume Ratio 0.7x vs 13-week average
Company Brief

What the company does

Kiniksa Pharmaceuticals Ltd. (KNSA) is an innovative biopharmaceutical company focused on addressing significant unmet medical needs through the development of advanced therapies. Its lead candidate, KPL-404, is a monoclonal antibody designed to modulate immune response, offering promising potential for the treatment of autoimmune disorders. With a strong pipeline supported by ongoing clinical trials and strategic partnerships, Kiniksa is well-positioned for growth in the competitive pharmaceutical market. The company’s commitment to scientific innovation and its goal of redefining treatment paradigms make it an attractive opportunity for institutional investors looking to invest in transformative biopharmaceutical solutions.

Snapshot

What the weekly tape is saying

KNSA closed the latest completed week at 51.89 USD. The 4-week return is -8.2% and the 12-week return is 12.6%. Trend Signal is active, Market Dynamics is -0.08. Setup signature: Balanced read with a 53/100 composite read.

Trend Signal Active
Market Dynamics No fresh buy
Price vs Trend 12.5%
Volume 0.7x
Setup Cockpit

A compressed read of the whole setup

The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.

Composite setup radar

Scoreboard

Trend 100 Persistence of active Trend Signal over the last year and current streak.
Momentum 43 Blend of 4-week and 12-week follow-through.
Dynamics 40 Latest Market Dynamics and whether pressure has improved over four weeks.
Relative Strength 68 Relative leadership and short-term RS change.
Volume 31 Participation compared with the 13-week volume baseline.
Risk Control 33 Drawdown and recent weekly volatility pressure.

16-week signal tape

27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 2 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun
Weekly return bar Trend Signal dot Positive Market Dynamics dot
Price Action

Price, Trend Line, and Fair Value

Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.

52-week price path

Price Trend Line Fair Value

Price map

Trend Line
46.10 USD
Vs Trend Line
12.5%
Fair Value
27.23 USD
Vs Fair Value
90.5%
52W High
59.87 USD
52W Low
26.27 USD
Drawdown
-13.3%
Range Position
76.3%
Momentum

Returns and trend persistence

Return windows separate the latest week from short-term and medium-term follow-through.

Return windows

1W 7.2%
4W -8.2%
12W 12.6%
26W 24.8%
52W 83.4%

Trend read

Active Streak
57 weeks
52W Active Weeks
52
52W Active Breadth
100.0%
Sector Scope
US Healthcare
Sector Rank
189 of 1038
Sector Percentile
81.9%
Peer Context

Sector and industry pulse

Peer breadth helps separate a stock-specific move from a broader group rotation.

Market Dynamics

Pressure, Relative Strength, and expectation

Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.

Dynamics path

Market Dynamics Relative Strength

Signal state

Market Dynamics
-0.08
4W MD Change
-110.0%
Relative Strength
7.85
4W RS Change
-63.9%
Expectation
Undecided
Probability
52.68%
Volume

Participation and confirmation

Volume tells us whether the latest weekly move is being confirmed by unusual participation.

52-week volume profile

Volume map

Latest Volume
2.4M
13W Average
3.2M
52W Average
2.9M
Vs 13W
0.7x
Vs 52W
0.8x
Risk Anatomy

Volatility, downside weeks, and return shape

A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.

26-week return distribution

Risk map

13W Volatility
9.4%
52W Volatility
6.4%
Upside Weeks
31
Downside Weeks
21
Downside Breadth
40.4%
Avg Gain / Loss
4.8% / -3.7%
Context

Classification, opportunities, risks, and watch points

Top-level read across company classification, constructive evidence, caution points, and the next things that matter.

Classification

Exchange
NASDAQ
Country
US
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Currency
USD
Market Cap
3.7B

Opportunity signals

  • Trend Signal is active with a 57-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.

Risk signals

  • Market Dynamics is negative, which weakens the current setup.
  • Recent volatility is running well above the one-year baseline.

Watch next

  • Trend Line remains the key weekly regime level.
  • Market Dynamics is the pressure gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Weekly Tape

Recent completed weeks

The latest weekly rows behind the report snapshot.

Week Close Return Trend Fair Value MD RS Volume Signal
12 Jun 2026 51.89 USD 7.2% 46.10 USD 27.23 USD -0.08 7.85 2.4M On
5 Jun 2026 48.42 USD 0.1% 45.72 USD 27.00 USD 0.25 3.49 2.7M On
29 May 2026 48.38 USD -9.1% 45.38 USD 26.79 USD 0.71 -0.92 2.4M On
22 May 2026 53.24 USD -5.8% 45.01 USD 26.57 USD 1.15 12.60 2.6M On
15 May 2026 56.51 USD -3.6% 44.53 USD 26.32 USD 0.81 21.72 2.2M On
8 May 2026 58.60 USD 6.0% 43.93 USD 26.04 USD 0.34 26.90 3.2M On
1 May 2026 55.27 USD 29.2% 43.24 USD 25.75 USD 0.01 27.35 7.5M On
24 Apr 2026 42.79 USD -4.7% 42.68 USD 25.49 USD -0.21 0.88 4.2M On
17 Apr 2026 44.90 USD -4.6% 42.47 USD 25.28 USD -0.11 8.93 3.4M On
10 Apr 2026 47.08 USD -3.6% 42.16 USD 25.07 USD 0.09 22.15 3.0M On
2 Apr 2026 48.82 USD 6.7% 41.82 USD 24.84 USD 0.05 33.71 1.9M On
27 Mar 2026 45.75 USD -0.7% 41.39 USD 24.59 USD 0.02 31.72 2.9M On
20 Mar 2026 46.08 USD 0.7% 40.98 USD 24.37 USD 0.12 29.67 3.6M On
13 Mar 2026 45.78 USD -0.8% 40.57 USD 24.15 USD 0.20 27.52 3.0M On